Nephrocare Health Services Limited IPO
Nephrocare Health Services Limited was a mainboard IPO in the Healthcare Service Provider sector, offered at ₹438–₹460 per share to raise ₹871 crore. The issue was subscribed 13.96× overall (QIBs 27.47×, NIIs 24.27×, retail 2.31×). It listed on 17 Dec 2025 at ₹490 and closed its first day at ₹471, a listing gain of +2.5% versus the ₹460 issue price. It now trades around ₹615 (+33.6% versus the issue price).
Frequently asked questions
- How many times was the Nephrocare Health Services Limited IPO subscribed?
- The Nephrocare Health Services Limited IPO was subscribed 13.96× overall — 27.47× in the QIB category, 24.27× among non-institutional investors, 2.31× in retail.
- What were the Nephrocare Health Services Limited IPO listing gains?
- Nephrocare Health Services Limited listed on 17 Dec 2025 at ₹490, closing its first day at ₹471 — a listing gain of +2.5% versus the ₹460 issue price.
- What were the retail allotment odds for the Nephrocare Health Services Limited IPO?
- Retail was subscribed 2.31×, so a single-lot application had roughly a 43.3% chance of allotment (about 1 in 2), and allotment was finalised on 15 Dec 2025.
- What was the price band and lot size of the Nephrocare Health Services Limited IPO?
- The price band was ₹438–₹460 per share, with a minimum lot of 32 shares (₹14,720 at the upper band).
- Who were the registrar and lead manager for the Nephrocare Health Services Limited IPO?
- KFin Technologies Limited was the registrar, and ICICI Securities was the book-running lead manager.